A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-β Peptides
An improved production and purification method for Alzheimer's disease related methionine-modified amyloid-β 1-40 and 1-42 peptides is proposed, taking advantage of the formation of inclusion body in Escherichia coli. A Thioflavin-S assay was set-up to evaluate inclusion body formation during g...
Saved in:
Published in | PloS one Vol. 11; no. 8; p. e0161209 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An improved production and purification method for Alzheimer's disease related methionine-modified amyloid-β 1-40 and 1-42 peptides is proposed, taking advantage of the formation of inclusion body in Escherichia coli. A Thioflavin-S assay was set-up to evaluate inclusion body formation during growth and optimize culture conditions for amyloid-β peptides production. A simple and fast purification protocol including first the isolation of the inclusion bodies and second, two cycles of high pH denaturation/ neutralization combined with an ultrafiltration step on 30-kDa cut-off membrane was established. Special attention was paid to purity monitoring based on a rational combination of UV spectrophotometry and SDS-PAGE analyses at the various stages of the process. It revealed that this chromatography-free protocol affords good yield of high quality peptides in term of purity. The resulting peptides were fully characterized and are appropriate models for highly reproducible in vitro aggregation studies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Current address: Unité Fonctionnalité et Ingénierie des Protéines, CNRS, Université de Nantes, Nantes, France Competing Interests: The authors have declared that no competing interests exist. These authors also contributed equally to this work. Current address: Institut de Chimie, UMR 7177, Université de Strasbourg, Strasbourg, France Conceptualization: CH PF EG IA MRS. Funding acquisition: EG CH IA MRS. Investigation: MH. Methodology: MH YM RI MRS. Project administration: EG MRS. Supervision: EG MRS. Validation: YM RI MRS. Visualization: MH. Writing - original draft: MH. Writing - review & editing: MH YM RI CH PF EG IA MRS. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0161209 |